Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Noble

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Neuropeptides|October 3, 2002
Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptorsF Noble, B P Roques
Journal of Evaluation in Clinical Practice|May 12, 2000
Patients attending a new drug clinic in 1990 and 1995: characteristics and outcomeF Noble, P J Robson
Brain Research|April 15, 1996
Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptorsF Noble, B M Cox
NIDA Research Monograph|January 1, 1995
Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addictionB P Roques, F Noble
Medical & Biological Engineering & Computing|May 1, 1978
Water-bath temperature controllerD F Noble, D Pearce
British Journal of Pharmacology|January 1, 1996
Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatmentF Noble, B M Cox
Progress in Neurobiology|June 15, 1999
CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacologyF Noble, B P Roques
Neurochemical Research|November 1, 1996
Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addictionB P Roques, F Noble
Journal of Steroid Biochemistry|July 1, 1986
Solubilization and partial purification of aromatase from chicken ovaryM Leshin, J F Noble
Journal of Neurochemistry|July 1, 1995
Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamenF Noble, B M Cox
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Neuropeptides|October 3, 2002
Phenotypes of mice with invalidation of cholecystokinin (CCK(1) or CCK(2)) receptorsF Noble, B P Roques
Journal of Evaluation in Clinical Practice|May 12, 2000
Patients attending a new drug clinic in 1990 and 1995: characteristics and outcomeF Noble, P J Robson
Brain Research|April 15, 1996
Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptorsF Noble, B M Cox
NIDA Research Monograph|January 1, 1995
Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addictionB P Roques, F Noble
Medical & Biological Engineering & Computing|May 1, 1978
Water-bath temperature controllerD F Noble, D Pearce
British Journal of Pharmacology|January 1, 1996
Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatmentF Noble, B M Cox
Progress in Neurobiology|June 15, 1999
CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacologyF Noble, B P Roques
Neurochemical Research|November 1, 1996
Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addictionB P Roques, F Noble
Journal of Steroid Biochemistry|July 1, 1986
Solubilization and partial purification of aromatase from chicken ovaryM Leshin, J F Noble
Journal of Neurochemistry|July 1, 1995
Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamenF Noble, B M Cox
Pageof 12